0001209191-23-037340.txt : 20230615
0001209191-23-037340.hdr.sgml : 20230615
20230615162333
ACCESSION NUMBER: 0001209191-23-037340
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PERRY GREGORY D
CENTRAL INDEX KEY: 0001236371
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 231017676
MAIL ADDRESS:
STREET 1: C/O IMMUNOGEN, INC.
STREET 2: 830 WINTER ST.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-14
0
0001651311
Merus N.V.
MRUS
0001236371
PERRY GREGORY D
C/O MERUS N.V.
UPPSALALAAN 17
UTRECHT
P7
3584 CT
NETHERLANDS
0
1
0
0
Chief Financial Officer
0
Share option (right to buy
26.50
2023-06-14
4
A
0
372924
0.00
A
2033-06-14
Common Shares
372924
372924
D
The options vest and become exercisable as to 25% of the underlying shares on the first anniversary of the date of grant, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter, such that the options shall be vested and exercisable as to all shares on the fourth anniversary of the date of grant, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date.
/s/ Peter Silverman as attorney-in-fact
2023-06-15